Literature DB >> 11098127

Nitric oxide reduces Ca(2+) and Zn(2+) influx through voltage-gated Ca(2+) channels and reduces Zn(2+) neurotoxicity.

B J Snider1, J Choi, D M Turetsky, L M Canzoniero, S L Sensi, C T Sheline, X Wang, S P Yu, D W Choi.   

Abstract

The translocation of synaptic Zn(2+) from nerve terminals into selectively vulnerable neurons may contribute to the death of these neurons after global ischemia. We hypothesized that cellular Zn(2+) overload might be lethal for reasons similar to cellular Ca(2+) overload and tested the hypothesis that Zn(2+) neurotoxicity might be mediated by the activation of nitric oxide synthase. Although Zn(2+) (30-300microM) altered nitric oxide synthase activity in cerebellar extracts in solution, it did not affect nitric oxide synthase activity in cultured murine neocortical neurons. Cultured neurons exposed to 300-500microM Zn(2+) for 5min under depolarizing conditions developed widespread degeneration over the next 24h that was unaffected by the concurrent addition of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine. Furthermore, Zn(2+) neurotoxicity was attenuated when nitric oxide synthase activity in the cultures was induced by exposure to cytokines, exogenous nitric oxide was added or nitric oxide production was pharmacologically enhanced. The unexpected protective effect of nitric oxide against Zn(2+) toxicity may be explained, at least in part, by reduction of toxic Zn(2+) entry. Exposure to nitric oxide donors reduced Ba(2+) current through high-voltage activated calcium channels, as well as K(+)-stimulated neuronal uptake of 45Ca(2+) or 65Zn(2+). The oxidizing agents thimerosal and 2,2'-dithiodipyridine also reduced K(+)-stimulated cellular 45Ca(2+) uptake, while akylation of thiols by pretreatment with N-ethylmaleimide blocked the reduction of 45Ca(2+) uptake by a nitric oxide donor.The results suggest that Zn(2+)-induced neuronal death is not mediated by the activation of nitric oxide synthase; rather, available nitric oxide may attenuate Zn(2+) neurotoxicity by reducing Zn(2+) entry through voltage-gated Ca(2+) channels, perhaps by oxidizing key thiol groups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098127     DOI: 10.1016/s0306-4522(00)00311-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Effects of levetiracetam on the production of nitric oxide--an in vivo study.

Authors:  Marie Dagonnier; Marie-Aline Laute; Massimo Pandolfo; Mario Manto
Journal:  J Neurol       Date:  2005-03-02       Impact factor: 4.849

2.  Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.

Authors:  K Hallén; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  Intracellular zinc elevation measured with a "calcium-specific" indicator during ischemia and reperfusion in rat hippocampus: a question on calcium overload.

Authors:  Christian J Stork; Yang V Li
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

4.  Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.

Authors:  Vera Ralevic
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

5.  Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats.

Authors:  Yang-Kai Wang; Du Shen; Qiang Hao; Qiang Yu; Zhao-Tang Wu; Yu Deng; Yan-Fang Chen; Wen-Jun Yuan; Qi-Kuan Hu; Ding-Feng Su; Wei-Zhong Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-16       Impact factor: 4.733

6.  Nitric oxide in the cerebellum of mutant mice.

Authors:  Mario-Ubaldo Manto; Hossein Fatemi
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

7.  Protective effects of voltage-gated calcium channel antagonists against zinc toxicity in SN56 neuroblastoma cholinergic cells.

Authors:  Marlena Zyśk; Beata Gapys; Anna Ronowska; Sylwia Gul-Hinc; Anna Erlandsson; Adam Iwanicki; Monika Sakowicz-Burkiewicz; Andrzej Szutowicz; Hanna Bielarczyk
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.